Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops

Pediatr Crit Care Med. 2004 May;5(3):282-5. doi: 10.1097/01.pcc.0000123548.73664.18.

Abstract

Objective: Brimonidine tartrate is a relatively selective alpha(2) adrenic agonist that lowers elevated intraocular pressure. A 2-yr-old boy presented with severe cardiorespiratory symptoms of systemic alpha(2) adrenergic intoxication after accidentally ingesting 2 mL of brimonidine ophthalmic solution (0.2%) orally. At 20 mins after ingestion, he became acutely pale and lethargic, with shallow infrequent respirations. The symptoms resolved completely within the next 10 hrs.

Methods: The pharmacokinetics of brimonidine in plasma and urine were analyzed using gas chromatography and mass spectrometry.

Results: Maximum plasma concentrations were 40 ng/mL 5 hrs after ingestion. The plasma elimination half-life value was 2.7 hrs. Elimination via urine was calculated as having a terminal half-life value of 3.2 hrs.

Conclusions: This case illustrates the ability of brimonidine to gain rapid access to the central nervous system. This first passage is followed by a redistribution phase with rising plasma concentrations. Children who accidentally ingest brimonidine orally should be admitted to a pediatric intensive care unit.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic alpha-Agonists / pharmacokinetics
  • Adrenergic alpha-Agonists / poisoning*
  • Brimonidine Tartrate
  • Child, Preschool
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Ophthalmic Solutions
  • Quinoxalines / administration & dosage
  • Quinoxalines / pharmacokinetics
  • Quinoxalines / poisoning*

Substances

  • Adrenergic alpha-Agonists
  • Ophthalmic Solutions
  • Quinoxalines
  • Brimonidine Tartrate